Projects per year
Personal profile
Personal profile
Dr. Andrew Farach is an associate professor in the Department of Radiation Oncology at Houston Methodist Hospital. His interest and special procedures are in breast cancer, brain cancer, gynecologic cancer, lung cancer, hepatobiliary cancer, gastrointestinal cancer, lymphoma, brachytherapy, stereotactic radiation/surgery.
Dr. Farach earned his medical degree from Thomas Jefferson University, Jefferson Medical College in Philadelphia. He completed his internship at the University of Texas Health Science Center and his radiation oncology residency training at Baylor College of Medicine. He became Director of Brachytherapy in the Department of Radiation Oncology at Houston Methodist in 2018. Dr. Farach is active in ASTRO (American Society of Therapeutic Radiology and Oncology), ACR (American College of Radiology), and the Texas Radiological Society (TRS). Dr. Farach has published peer-reviewed articles on topics such as SBRT outcomes in lung cancer, radiation and immunotherapy for breast cancer, and liver regeneration after SBRT. He plays an important role in cancer patient care, clinical research and the education of residents and students.
External positions
Associate Professor of Clinical Radiation Oncology, Weill Cornell Medicine
Nov 1 2022 → …
Research Area Keywords
- Imaging & Radiology
- Cancer
- Clinical Translation & Trials
- Clinical Care
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
HIGH DOSE RATE BRACHYTHERAPY PRIOR TO ROBOTIC ASSISTED LAPAROSCOPIC PROSTATECTOMY WITH SELECTIVE ADJUVANT ADVANCED ANDROGEN BLOCKADE FOR LOCALIZED HIGH-RISK PROSTATE CANCER (NEOHDR-B)
Farach, A. M. (PI), Butler, E. B. (Key Personnel), Mathur, S. (Key Personnel), Miles, B. J. (Key Personnel), Satkunasivam, R. (Key Personnel) & Teh, B. S. (Key Personnel)
12/23/24 → …
Project: Clinical Trial
-
A Phase II Clinical tRial of neoADjuVant sAsanlimab and stereotaCtiC body radIatioN thErapy as an in situ vaccine for cisplatin-ineligible Muscle Invasive Bladder Cancer (RAD VACCINE MIBC)
Satkunasivam, R. (PI), Butler, E. B. (Key Personnel), Chan, K. S. (Key Personnel), Chen, S.-H. (Key Personnel), Esnaola, N. F. (Key Personnel), Farach, A. M. (Key Personnel), Teh, B. S. (Key Personnel) & Zhang, J. (Key Personnel)
1/20/22 → …
Project: Clinical Trial
-
EF-32 - TRIDENT A Pivotal Randomized, Open-label Study of Optune® (TTFields, 200kHz) Concomitant with Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
Baskin, D. S. (PI), Farach, A. M. (Key Personnel) & Teh, B. S. (Key Personnel)
9/29/21 → …
Project: Clinical Trial
-
TAILOR RT: A RANDOMIZED TRIAL OF REGIONAL RADIOTHERAPY IN BIOMARKER LOW RISK NODE POSITIVE AND T3N0 BREAST CANCER
Teh, B. S. (PI), Chang, J. C. (CoI), Farach, A. M. (CoI), Haque, W. M. (CoI), Morgan, P. B. (CoI), Niravath, P. A. (CoI), Shadle, K. M. (CoI), Shkedy, C. (CoI) & Singh, M. (CoI)
5/30/18 → 5/29/28
Project: Non Profit
-
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination withIntravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVACancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Zaid, T. (PI), Butler, E. B. (CoI), Darcourt, J. (CoI), Farach, A. M. (CoI), Kamat, A. A. (CoI), Shkedy, C. (CoI), Singh, M. (CoI) & Suri, A. (CoI)
3/1/14 → 2/28/39
Project: Non Profit
-
Development and implementation of a brachytherapy procedure scoring system to optimize clinic and physics staffing schedule: A retrospective study of a single institution with a busy brachytherapy program
Baghwala, A., Li, C., Olek, D., Ivey, F., Pino, R. & Farach, A., Jan 1 2025, In: Brachytherapy. 24, 1, p. 190-196 7 p.Research output: Contribution to journal › Article › peer-review
-
HDR brachytherapy salvage for nodular prostate fossa recurrence: A mechanistic review and initial report of clinical outcomes
Andring, L. M., Krc, R. F., Paradise, E., Li, B., Baghwala, A., Miles, B., Satkunasivam, R., Kaushik, D., Pino, R., Teh, B. S., Butler, E. B. & Farach, A. M., May 1 2025, In: Brachytherapy. 24, 3, p. 404-412 9 p.Research output: Contribution to journal › Article › peer-review
-
Treatment of a Buschke-Löwenstein Tumor With Radiotherapy and Cemiplimab
Farach, A. M., Paradise, E. & Kieser, R. B., Jan 15 2025, (E-pub ahead of print) In: JAMA Dermatology. 161, 3, p. 336-338 3 p.Research output: Contribution to journal › Article › peer-review
-
Challenges in differentiating between primary cervical cancer versus stage II endometrial cancer
Alvarenga-Bezerra, V., Santía, M. C., Meschini, T., Deavers, M., Farach, A. M. & Ramirez, P. T., Dec 2 2024, In: International Journal of Gynecological Cancer. 34, 12, p. 1976-1979 4 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparative real-world survival outcomes of muscle-invasive bladder cancer treated with bladder-only vs. whole-pelvis concurrent chemoradiation
Riveros, C., Ranganathan, S., Haque, W., Huang, E., Xu, J., Kulkarni, G. S., Geng, M., Anis, M., Muhammad, T., Chan, K. S., Farach, A., Teh, B. S., Miles, B. J., Klaassen, Z., Sonpavde, G. P., Wallis, C. J. D. & Satkunasivam, R., Feb 2024, In: Journal of the Canadian Urological Association. 18, 2, p. 17-24 8 p.Research output: Contribution to journal › Article › peer-review
Open Access